Botanical drugs and their natural compounds: a neglected treasury for inhibiting the carcinogenesis of pancreatic ductal adenocarcinoma
Context Pancreatic ductal adenocarcinoma (PDAC), which is characterized by its malignant nature, presents challenges for early detection and is associated with a poor prognosis. Any strategy that can interfere with the beginning or earlier stage of PDAC greatly delays disease progression. In respons...
Saved in:
Main Authors: | Yunfei Dai (Author), Xi Guan (Author), Fangyue Guo (Author), Xin Kong (Author), Shuqi Ji (Author), Dong Shang (Author), Changchuan Bai (Author), Qingkai Zhang (Author), Liang Zhao (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021) -
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021) -
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021) -
Biliary Tract Microbiota Similarities in Pancreatic Ductal Adenocarcinoma
by: Ariel A. Arteta
Published: (2021)